"Mr. Shawn Leon, Company CEO, reported, "The closing of this deal is the result of a lot of hard work and effort and has directly benefited our shareholders. It is a huge improvement in the overall health of the Company. We have managed to keep our issued common stock static since March 2, 2022, which was difficult given the large amount of convertible debt we carried throughout that time. This real estate deal has eliminated a lot of debt, including all variable rate convertible debt and the Company is now free to focus on growth."
*** The Company For the Nine Months, Sales was USD 3.59 million compared to USD 1.05 million a year ago.
***Net income was USD 0.115058 million compared to net loss of USD 3.44 million a year ago. *
Here are the numbers for the so called record high quarterly earnings for the treatment center. Revenue for this business model as stated in the filing is what is billed to the insurers. So they can play with revenue as long as they match with expenses otherwise they will need to show cash from operations. In this case we see a year over year increase in revenue of 37.6%, but expenses were up 41.2% resulting in an operating income decrease of 37.9%.
The July 17th statement boasts a result in '...ARIA’s highest quarterly profit to date...'. Reconcile that statement with a decrease of 37.9% in year over year operating income. It has really gotten to the point where they simply print what they like regardless of reality all the while knowing that someone is going to call them on it.
prof·it /'präf?t/ noun a financial gain, especially the difference between the amount earned and the amount spent in buying, operating, or producing something.
The Company further reports that its ARIA subsidiary’s extremely strong results in April and May continued in June and overall revenue for the ARIA subsidiary will be approximately $1,450,000 for the quarter, which will result in ARIA’s highest quarterly profit to date. The second quarter results will be released before August 14, 2023.
Revenues Revenues were $1,565,959 and $1,138,032 for the three months ended June 30, 2023 and 2022, respectively, an increase of $427,927 or 37.6%.
Operating Expenses Operating expenses were $1,533,813 and $1,086,270 for the three months ended June 30, 2023 and 2022, respectively, an increase of $447,543 or 41.2%.
Operating income Operating income was $32,146 and $51,762 for the three months ended June 30, 2023 and 2022, respectively, a decrease of $19,616 or 37.9%.